The role of compartment penetration in PI-monotherapy: the Atazanavir-Ritonavir Monomaintenance (ATARITMO) Trial.

Vernazza, Pietro; Daneel, Synøve; Schiffer, Véronique; Decosterd, Laurent; Fierz, Walter; Klimkait, Thomas; Hoffmann, Matthias; Hirschel, Bernard

Vernazza, Pietro; Daneel, Synøve; Schiffer, Véronique; Decosterd, Laurent; Fierz, Walter; Klimkait, Thomas; Hoffmann, Matthias; Hirschel, Bernard.

Affiliation

Vernazza P; Division of Infectious Diseases, Department of Internal Medicine, Cantonal Hospital St. Gallen, 9007 St. Gallen, Switzerland. Pietro.Vernazza@kssg.ch

AIDS ; 21(10): 1309-15, 2007 Jun 19.

Article in En | MEDLINE | ID: mdl-17545707

Subject(s)

HIV Infections/drug therapy; HIV Protease Inhibitors/administration & dosage; Oligopeptides/administration & dosage; Pyridines/administration & dosage; Ritonavir/administration & dosage; Adult; Atazanavir Sulfate; C-Reactive Protein/analysis; CD4 Lymphocyte Count; CD8 Antigens/analysis; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV/immunology; HIV Infections/cerebrospinal fluid; HIV Infections/metabolism; HIV Protease Inhibitors/analysis; Humans; Male; Oligopeptides/analysis; Pilot Projects; Pyridines/analysis; RNA, Viral/analysis; Semen/virology; Treatment Outcome; Viral Load

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Oligopeptides / Pyridines / HIV Infections / HIV Protease Inhibitors / Ritonavir Type of study: Guideline / Prognostic_studies Limits: Adult / Female / Humans / Male Language: En Journal: AIDS Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2007 Type: Article Affiliation country: Switzerland

Search on Google

Add to My VHL

XML

PubMed Links